Co-founded in 2009 by Claude Claret (Horus Pharma), Pierre-Paul Elena (Iris Pharma), Prof. Pierre Gastaud (Nice University Hospital) and Dr. Loïc Lozivit (ophthalmologist, Nice), Ophta Biotech brings together actors in diagnostics, therapy and research in ophthalmology for patient associations in the Mediterranean arc.
Based on the pooling of multidisciplinary expertise and dialogue with patients, Ophta Biotech promotes the emergence of projects and new tools for visually impaired people. The main tasks of the association are to:
Ophta Biotech is a member of Eurobiomed, competitiveness cluster in the Health industry that actively supports the dynamic of research initiated by the association.
Established at the Vision Institute since 2008, Horus Pharma benefits from an advanced research environment, internationally recognised for its work in ophthalmology.